Fiore Michael Henry sold $298K of HQY
Fiore Michael Henry (EVP, CHIEF COMMERCIAL OFFICER) sold 3,142 shares of HEALTHEQUITY, INC. (HQY) at $95.00 ($0.30M total) on 2026-05-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is under a pre-arranged 10b5-1 plan, typically viewed as lower information content than unscheduled selling.
Market read
Traders may monitor for follow-on insider activity, but this specific disclosure alone is unlikely to drive a fundamental repricing.
What to watch
The filing excerpt doesn’t state total compensation context, diversification needs, or whether other insiders are buying/selling around the same period.
Background
The article is a SEC EDGAR Form 4 insider transaction disclosure for HEALTHEQUITY (HQY).
Ticker impact
HEALTHEQUITY’s EVP/Chief Commercial Officer sold 3,142 shares in an open-market transaction disclosed on SEC Form 4.
Likely limited near-term impact; any effect is more about positioning/flow than new fundamentals.
Form 4 shows a scheduled 10b5-1 sale (not discretionary timing), with no accompanying earnings, guidance, or operational change in the filing excerpt.
Market effects
Minimal—this is company-specific insider activity with no sector-wide catalyst indicated.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still coincide with internal risk perceptions; traders may treat it as a mild caution signal.
Key entities
- issuerHEALTHEQUITY, INC.
Subject of the Form 4 insider transaction; shares sold by an EVP/Chief Commercial Officer.
- insiderFiore Michael Henry
EVP, Chief Commercial Officer who sold 3,142 shares at $95.00 on 2026-05-29 (reported via Form 4 filed 2026-06-02).
